Jeffrey Trigilio
2021
In 2021, Jeffrey Trigilio earned a total compensation of $2.7M as Chief Financial Officer at Cullinan Therapeutics, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $220,000 |
|---|---|
| Option Awards | $2,032,777 |
| Salary | $400,000 |
| Other | $14,500 |
| Total | $2,667,277 |
Trigilio received $2M in option awards, accounting for 76% of the total pay in 2021.
Trigilio also received $220K in bonus, $400K in salary and $14.5K in other compensation.
Rankings
In 2021, Jeffrey Trigilio's compensation ranked 4,893rd out of 12,415 executives tracked by ExecPay. In other words, Trigilio earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,893 out of 12,415 | 61st |
Division Manufacturing | 2,049 out of 5,508 | 63rd |
Major group Chemicals And Allied Products | 868 out of 2,378 | 64th |
Industry group Drugs | 778 out of 2,099 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 197 out of 449 | 56th |
Source: SEC filing on April 29, 2022.
Trigilio's colleagues
We found three more compensation records of executives who worked with Jeffrey Trigilio at Cullinan Therapeutics in 2021.